Renata Jaskula‐Sztul

2.4k total citations
67 papers, 1.9k citations indexed

About

Renata Jaskula‐Sztul is a scholar working on Molecular Biology, Epidemiology and Oncology. According to data from OpenAlex, Renata Jaskula‐Sztul has authored 67 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 29 papers in Epidemiology and 23 papers in Oncology. Recurrent topics in Renata Jaskula‐Sztul's work include Neuroendocrine Tumor Research Advances (29 papers), Lung Cancer Research Studies (14 papers) and Neuroblastoma Research and Treatments (13 papers). Renata Jaskula‐Sztul is often cited by papers focused on Neuroendocrine Tumor Research Advances (29 papers), Lung Cancer Research Studies (14 papers) and Neuroblastoma Research and Treatments (13 papers). Renata Jaskula‐Sztul collaborates with scholars based in United States, Poland and Mexico. Renata Jaskula‐Sztul's co-authors include Herbert Chen, Muthusamy Kunnimalaiyaan, April D. Harrison, Ajitha Dammalapati, Shaoqin Gong, Ning Li, Wenjin Xu, Krzysztof Szyfter, Witold Szyfter and Guojun Chen and has published in prestigious journals such as PLoS ONE, Biomaterials and Advanced Functional Materials.

In The Last Decade

Renata Jaskula‐Sztul

65 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Renata Jaskula‐Sztul United States 27 1.0k 508 289 286 233 67 1.9k
Wenyu Li China 24 1.7k 1.6× 341 0.7× 319 1.1× 77 0.3× 214 0.9× 60 2.6k
Yue Wu China 29 1.0k 1.0× 257 0.5× 204 0.7× 458 1.6× 428 1.8× 110 2.3k
Shamit K. Dutta United States 31 1.6k 1.5× 723 1.4× 139 0.5× 350 1.2× 565 2.4× 62 2.6k
Chalet Tan United States 26 1.2k 1.1× 351 0.7× 133 0.5× 384 1.3× 507 2.2× 47 2.3k
Jie Gao China 24 910 0.9× 251 0.5× 106 0.4× 235 0.8× 296 1.3× 90 1.7k
Angel L. Armesilla United Kingdom 30 1.6k 1.6× 507 1.0× 366 1.3× 188 0.7× 416 1.8× 50 2.8k
Christine Pirker Austria 31 1.4k 1.4× 1.0k 2.1× 227 0.8× 175 0.6× 448 1.9× 92 3.0k
Vijay Pandey China 30 1.4k 1.3× 658 1.3× 155 0.5× 137 0.5× 706 3.0× 105 2.5k
Frances L. Byrne Australia 22 1.2k 1.2× 166 0.3× 240 0.8× 117 0.4× 603 2.6× 53 1.9k
Jan Hraběta Czechia 23 1.6k 1.6× 606 1.2× 153 0.5× 138 0.5× 273 1.2× 53 2.5k

Countries citing papers authored by Renata Jaskula‐Sztul

Since Specialization
Citations

This map shows the geographic impact of Renata Jaskula‐Sztul's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Renata Jaskula‐Sztul with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Renata Jaskula‐Sztul more than expected).

Fields of papers citing papers by Renata Jaskula‐Sztul

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Renata Jaskula‐Sztul. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Renata Jaskula‐Sztul. The network helps show where Renata Jaskula‐Sztul may publish in the future.

Co-authorship network of co-authors of Renata Jaskula‐Sztul

This figure shows the co-authorship network connecting the top 25 collaborators of Renata Jaskula‐Sztul. A scholar is included among the top collaborators of Renata Jaskula‐Sztul based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Renata Jaskula‐Sztul. Renata Jaskula‐Sztul is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lynch, Shannon E., Hailey Houson, Jason Whitt, et al.. (2025). Characterizing SSTR2 expression and modulation for targeted imaging and therapy in preclinical models of triple-negative breast cancer. Scientific Reports. 15(1). 9988–9988.
2.
Gillis, Andrea, Dezhi Wang, Rachael Guenter, et al.. (2023). Somatostatin Receptor Type 2 and Thyroid-Stimulating Hormone Receptor Expression in Oncocytic Thyroid Neoplasms: Implications for Prognosis and Treatment. Modern Pathology. 36(12). 100332–100332. 4 indexed citations
3.
Whitt, Jason, Hailey Houson, Rachael Guenter, et al.. (2023). Thyroid-stimulating hormone receptor (TSHR) as a target for imaging differentiated thyroid cancer. Surgery. 175(1). 199–206. 10 indexed citations
4.
Monavarian, Mehri, Kathleen O’Connell, Diego Altomare, et al.. (2022). Reciprocal SOX2 regulation by SMAD1-SMAD3 is critical for anoikis resistance and metastasis in cancer. Cell Reports. 40(4). 111066–111066. 27 indexed citations
5.
Jang, Samuel, Jason Whitt, Kayla F. Goliwas, et al.. (2021). Ex Vivo Modeling of Human Neuroendocrine Tumors in Tissue Surrogates. Frontiers in Endocrinology. 12. 710009–710009. 7 indexed citations
6.
Whitt, Jason, Chee Paul Lin, James Bibb, et al.. (2020). Non-toxic fragment of botulinum neurotoxin type A and monomethyl auristatin E conjugate for targeted therapy for neuroendocrine tumors. Cancer Gene Therapy. 27(12). 898–909. 3 indexed citations
7.
Whitt, Jason, Tolulope A. Aweda, Rachael Guenter, et al.. (2019). A growth model of neuroendocrine tumor surrogates and the efficacy of a novel somatostatin-receptor–guided antibody-drug conjugate: Perspectives on clinical response?. Surgery. 167(1). 197–203. 4 indexed citations
8.
Si, Yingnan, Seulhee Kim, Eric Erquan Zhang, et al.. (2019). Targeted Exosomes for Drug Delivery: Biomanufacturing, Surface Tagging, and Validation. Biotechnology Journal. 15(1). e1900163–e1900163. 61 indexed citations
9.
Si, Yingnan, Norio Yasui, Yichen Guo, et al.. (2018). Bioprocess development of antibody-drug conjugate production for cancer treatment. PLoS ONE. 13(10). e0206246–e0206246. 26 indexed citations
10.
Yu, Xiao-Min, Renata Jaskula‐Sztul, Glen Leverson, et al.. (2016). Notch1 Signaling Regulates the Aggressiveness of Differentiated Thyroid Cancer and Inhibits SERPINE1 Expression. Clinical Cancer Research. 22(14). 3582–3592. 33 indexed citations
11.
Jaskula‐Sztul, Renata, Wenjin Xu, Guojun Chen, et al.. (2016). Thailandepsin A-loaded and octreotide-functionalized unimolecular micelles for targeted neuroendocrine cancer therapy. Biomaterials. 91. 1–10. 55 indexed citations
12.
Chen, Guojun, Renata Jaskula‐Sztul, April D. Harrison, et al.. (2016). KE108-conjugated unimolecular micelles loaded with a novel HDAC inhibitor thailandepsin-A for targeted neuroendocrine cancer therapy. Biomaterials. 97. 22–33. 44 indexed citations
13.
Eide, Jacob G., et al.. (2015). Chrysin suppresses achaete-scute complex-like 1 and alters the neuroendocrine phenotype of carcinoids. Cancer Gene Therapy. 22(10). 496–505. 4 indexed citations
14.
Jaskula‐Sztul, Renata, Jacob G. Eide, Ajitha Dammalapati, et al.. (2014). Tumor-Suppressor Role of Notch3 in Medullary Thyroid Carcinoma Revealed by Genetic and Pharmacological Induction. Molecular Cancer Therapeutics. 14(2). 499–512. 38 indexed citations
15.
Yu, Xiao-Min, et al.. (2014). Hesperetin Activates the Notch1 Signaling Cascade, Causes Apoptosis, and Induces Cellular Differentiation in Anaplastic Thyroid Cancer. Annals of Surgical Oncology. 21(S4). 497–504. 66 indexed citations
16.
Jaskula‐Sztul, Renata, et al.. (2013). Resveratrol Induces Differentiation Markers Expression in Anaplastic Thyroid Carcinoma via Activation of Notch1 Signaling and Suppresses Cell Growth. Molecular Cancer Therapeutics. 12(7). 1276–1287. 95 indexed citations
17.
Yu, Xiaomin, et al.. (2012). Chrysin activates Notch1 signaling and suppresses tumor growth of anaplastic thyroid carcinoma in vitro and in vivo. Cancer. 119(4). 774–781. 81 indexed citations
18.
Wyche, Thomas P., et al.. (2012). Thiocoraline Regulates Neuroendocrine Phenotype and Inhibits Proliferation in Carcinoid Tumor Cells. Journal of Surgical Research. 172(2). 237–237. 3 indexed citations
19.
Holen, Kyle D., Renata Jaskula‐Sztul, Daniel Mulkerin, et al.. (2011). A Pilot Phase II Study of Valproic Acid for Treatment of Low-Grade Neuroendocrine Carcinoma. The Oncologist. 16(6). 835–843. 72 indexed citations
20.
Jaskula‐Sztul, Renata, et al.. (2011). Expression of the Active Notch1 Decreases MTC Tumor Growth In Vivo. Journal of Surgical Research. 171(1). 23–27. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wenyu Li Breakdown of academic impact, for papers by Yue Wu Breakdown of academic impact, for papers by Shamit K. Dutta Breakdown of academic impact, for papers by Chalet Tan Breakdown of academic impact, for papers by Jie Gao Breakdown of academic impact, for papers by Angel L. Armesilla Breakdown of academic impact, for papers by Christine Pirker Breakdown of academic impact, for papers by Vijay Pandey Breakdown of academic impact, for papers by Frances L. Byrne Breakdown of academic impact, for papers by Jan Hraběta
Rankless by CCL
2026